Back to Agenda
Session 2: An Overview of the ANDA Review Process
Speaker(s)
An Overview of the ANDA Review Process
Sarah Ibrahim, PharmD, PhD
FDA, United States
Associate Director for Stakeholder and Global Engagement, Office of Generic Drug
Have an account?